Open AccessMiR-495 is a Predictive Biomarker that Downregulates GFI1 Expression in Medulloblastoma
Author(s) -
Ce Wang,
Zhiyuan Yun,
Tianshu Zhao,
Xian Liu,
Xueling Ma
Publication year - 2015
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000430308
Subject(s) - medulloblastoma , immunohistochemistry , biomarker , cancer research , taqman , microrna , real time polymerase chain reaction , biology , pathology , oncology , medicine , gene , genetics
Alterations in the expression level of miR-495 were recently observed in various tumours. Medulloblastoma is the most common malignant brain tumour in children. However, the clinical significance of miR-495 in medulloblastomas remains unclear.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom